Europe Approves Roche’s First Bispecific Antibody for Two Eyes…
That European Commission approved Roche Holding Ltd RHHBY Vabysmo (faricimab) for neovascular or “wet” age-related macular degeneration (nAMD) and visual impairment due to diabetic macular